Search

  • HOME
  • Search
Original Article
1679
Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients
Ka Shing Cheung, Lok Ka Lam, Rex Wan Hin Hui, Xianhua Mao, Ruiqi R Zhang, Kwok Hung Chan, Ivan FN Hung, Wai Kay Seto, Man-Fung Yuen
Clin Mol Hepatol. 2022;28(3):553-564.   Published online May 11, 2022
View: 791   Download: 56
1677
Reappraisal of sepsis-3 and CLIF-SOFA as predictors of mortality in patients with cirrhosis and infection presenting to the emergency department: A multicenter study
Ji Hyun Kim, Baek Gyu Jun, Minjong Lee, Hye Ah Lee, Tae Suk Kim, Jeong Won Heo, Da Hye Moon, Seong Hee Kang, Ki Tae Suk, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim, Dae Hee Choi
Clin Mol Hepatol. 2022;28(3):540-552.   Published online May 6, 2022
View: 753   Download: 36
Review
1692
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim
Clin Mol Hepatol. 2022;28(3):425-472.   Published online July 1, 2022
View: 1018   Download: 100
Snapshot
1662
Acute on chronic liver failure in cirrhosis
Marta Tonon, Salvatore Piano
Clin Mol Hepatol. 2022;28(2):273-275.   Published online February 14, 2022
View: 1301   Download: 71
Letter to the Editor
Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
Jihyun An, Ju Hyun Shim
Clin Mol Hepatol. 2022;28(2):267-268.   Published online January 18, 2022
View: 934   Download: 28
Original Article
1655
Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats
Ki Tae Yoon, Hongqun Liu, Jing Zhang, Sojung Han, Samuel S. Lee
Clin Mol Hepatol. 2022;28(2):232-241.   Published online January 5, 2022
View: 1500   Download: 58  Citation: 1
1623
Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
Ji Won Han, Da In Kim, Hee Chul Nam, U Im Chang, Jin Mo Yang, Do Seon Song
Clin Mol Hepatol. 2022;28(2):219-231.   Published online July 20, 2021
View: 14901   Download: 219  Citations: 3
Editorial
1628
Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
Takumi Kawaguchi, Takuji Torimura
Clin Mol Hepatol. 2022;28(2):177-180.   Published online August 26, 2021
View: 1707   Download: 94
Review
1636
The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
Hae Lim Lee, Sung Won Lee
Clin Mol Hepatol. 2022;28(2):121-134.   Published online September 27, 2021
View: 2279   Download: 228
Original Article
1642
U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
Huapeng Lin, Grace Lai-Hung Wong, Xinrong Zhang, Terry Cheuk-Fung Yip, Ken Liu, Yee Kit Tse, Vicki Wing-Ki Hui, Jimmy Che-To Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong
Clin Mol Hepatol. 2022;28(1):77-90.   Published online November 5, 2021
View: 2006   Download: 84  Citations: 4
1638
Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
Jihyun An, Hyung-Don Kim, Seon-Ok Kim, Ha Il Kim, Gi-Won Song, Han Chu Lee, Ju Hyun Shim
Clin Mol Hepatol. 2022;28(1):67-76.   Published online October 12, 2021
View: 2035   Download: 143  Citations: 2
Review
1626
Current knowledge about biomarkers of acute kidney injury in liver cirrhosis
Han Ah Lee, Yeon Seok Seo
Clin Mol Hepatol. 2022;28(1):31-46.   Published online August 2, 2021
View: 2574   Download: 179  Citation: 1
Original Article
1622
Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, Chun-Jen Liu, Ching-Chu Lo, Ke-Jhang Huang, Jyh-Jou Chen, Kuo-Chih Tseng, Chi-Yang Chang, Cheng-Yuan Peng, Yu-Lueng Shih, Chia-Sheng Huang, Wei-Yu Kao, Sheng-Shun Yang, Ming-Chang Tsai, Jo-Hsuan Wu, Po-Yueh Chen, Pei-Yuan Su, Jow-Jyh Hwang, Yu-Jen Fang, Pei-Lun Lee, Chi-Wei Tseng, Fu-Jen Lee, Hsueh-Chou Lai, Tsai-Yuan Hsieh, Chun-Chao Chang, Chung-Hsin Chang, Yi-Jie Huang, Jia-Horng Kao
Clin Mol Hepatol. 2021;27(4):575-588.   Published online July 13, 2021
View: 4693   Download: 938  Citations: 2
Review
1617
Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
Ho Soo Chun, A Reum Choe, Minjong Lee, Yuri Cho, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
Clin Mol Hepatol. 2021;27(4):535-552.   Published online June 16, 2021
View: 4782   Download: 361  Citation: 1
Special Topic
Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline
Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
Clin Mol Hepatol. 2021;27(4):515-523.   Published online September 17, 2021
View: 2967   Download: 55  Citation: 1
Review
1611
β-blockers in advanced cirrhosis: More friend than enemy
Ki Tae Yoon, Hongqun Liu, Samuel S. Lee
Clin Mol Hepatol. 2021;27(3):425-436.   Published online December 3, 2020
View: 2381   Download: 176  Citations: 3
Letter to the Editor
Clinical and serological prognostic markers in primary biliary cholangitis
Markus Wilhelmi
Clin Mol Hepatol. 2021;27(2):360-361.   Published online March 23, 2021
View: 1657   Download: 83
Original Article
1582
Association between new-onset liver cirrhosis and suicide risk in South Korea: A nationwide cohort study
Suk-Yong Jang, Woo Sun Rou, Seok Hyun Kim, Byung Seok Lee, Hyuk Soo Eun
Clin Mol Hepatol. 2021;27(2):283-294.   Published online December 3, 2020
View: 2504   Download: 156  Citations: 4
Editorial
A need for patient-centered care in managing patients with liver cirrhosis
Eileen L. Yoon
Clin Mol Hepatol. 2021;27(2):270-272.   Published online January 27, 2021
View: 1574   Download: 75
Review
1585
Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
Karn Wijarnpreecha, Elizabeth S. Aby, Aijaz Ahmed, Donghee Kim
Clin Mol Hepatol. 2021;27(2):221-235.   Published online December 3, 2020
View: 3761   Download: 300  Citations: 11
Original Article
1595
The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis
Se Ri Ryu, Jeong-Ju Yoo, Seong Hee Kang, Soung Won Jeong, Moon Young Kim, Young Kyu Cho, Young Chang, Sang Gyune Kim, Jae Young Jang, Young Seok Kim, Soon Koo Baik, Yong Jae Kim, Su Yeon Park, Baigal Baymbajav
Clin Mol Hepatol. 2021;27(1):197-206.   Published online December 3, 2020
View: 3188   Download: 126  Citations: 4
1572
Alcohol associated liver cirrhotics have higher mortality after index hospitalization: Long-term data of 5,138 patients
Priyanka Jain, Saggere Muralikrishna Shasthry, Ashok Kumar Choudhury, Rakhi Maiwall, Guresh Kumar, Ankit Bharadwaj, Vinod Arora, Rajan Vijayaraghavan, Ankur Jindal, Manoj Kumar Sharma, Vikram Bhatia, Shiv Kumar Sarin
Clin Mol Hepatol. 2021;27(1):175-185.   Published online December 3, 2020
View: 2595   Download: 97  Citations: 3
Editorial
The cutoff of transient elastography for the evaluation of portal hypertension should be different according to the etiology?
Beom Kyung Kim
Clin Mol Hepatol. 2021;27(1):91-93.   Published online December 3, 2020
View: 1788   Download: 67
Review
1579
The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
Yusuke Watanabe, Atsunori Tsuchiya, Shuji Terai
Clin Mol Hepatol. 2021;27(1):70-80.   Published online December 3, 2020
View: 5745   Download: 286  Citations: 17
Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)
The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
Jong Hwa Choi, Won Sohn, Yong Kyun Cho
Clin Mol Hepatol. 2020;26(4):662-669.   Published online September 25, 2020
View: 4663   Download: 136  Citations: 11
Original Article
Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea
Yu Rim Lee, Min Kyu Kang, Jeong Eun Song, Hyun Jung Kim, Young Oh Kweon, Won Young Tak, Se Young Jang, Jung Gil Park, Changhyeong Lee, Jae Seok Hwang, Byoung Kuk Jang, Jeong Ill Suh, Woo Jin Chung, Byung Seok Kim, Soo Young Park
Clin Mol Hepatol. 2020;26(4):562-576.   Published online October 1, 2020
View: 3413   Download: 160  Citations: 14
Editorial
More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis
Paul Kwo, Deepti Dronamraju
Clin Mol Hepatol. 2020;26(4):489-491.   Published online September 24, 2020
View: 2129   Download: 61  Citation: 1
Review
1547
Managing liver cirrhotic complications: Overview of esophageal and gastric varices
Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani
Clin Mol Hepatol. 2020;26(4):444-460.   Published online October 1, 2020
View: 5764   Download: 416  Citations: 23
Original Article
Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir
Seung Bum Lee, Joonho Jeong, Jae Ho Park, Seok Won Jung, In Du Jeong, Sung-Jo Bang, Jung Woo Shin, Bo Ryung Park, Eun Ji Park, Neung Hwa Park
Clin Mol Hepatol. 2020;26(3):364-375.   Published online May 29, 2020
View: 3312   Download: 224  Citations: 12
Editorial
Low-level viremia in patients undergoing antiviral therapy: Does it indicate time for a change?
Jung Hee Kim, Dong Hyun Sinn
Clin Mol Hepatol. 2020;26(3):315-317.   Published online June 23, 2020
View: 2623   Download: 85
1 | 2 | 3 | 4 | 5 | 6 | 7 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 325
TOTAL : 924106
Close layer